Invesaro

Stocks PAVM Earnings

Earnings

PAVmed Inc. (PAVM) earnings

Quarterly results of PAVmed Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when PAVM files with the SEC.

Next earnings date

PAVmed Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) PAVmed Inc. reported revenue of $33K (+450% on the same quarter a year earlier) and a net loss of $5.4M.

Diluted earnings per share were -$0.87.

Filed with the SEC on August 13, 2026.

Revenue by quarter
Q3 24: $1M $1M Q3 24Q4 24: -$10K -$10K Q4 24Q1 25: $8K $8K Q1 25Q2 25: $6K $6K Q2 25Q3 25: $5K $5K Q3 25Q4 25: $52K $52K Q4 25Q1 26: $22K $22K Q1 26Q2 26: $33K $33K Q2 26
Net income by quarter
Q3 24: $64.4M $64.4M Q3 24Q4 24: $1.4M $1.4M Q4 24Q1 25: $19M $19M Q1 25Q2 25: -$11.9M -$11.9M Q2 25Q3 25: -$5.4M -$5.4M Q3 25Q4 25: -$1.3M -$1.3M Q4 25Q1 26: -$60K -$60K Q1 26Q2 26: -$5.4M -$5.4M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$33K+450%-$5.4M-$0.87
Q1 FY2026March 31, 2026$22K+175%-$60K-$4.42
Q4 FY2025December 31, 2025$52K--$1.3M-
Q3 FY2025September 30, 2025$5K-99.5%-$5.4M-$0.29
Q2 FY2025June 30, 2025$6K--$11.9M-$22.08
Q1 FY2025March 31, 2025$8K-$19M$10.10
Q4 FY2024December 31, 2024-$10K-$1.4M-
Q3 FY2024September 30, 2024$1M-$64.4M$1.44

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is PAVmed Inc.'s next earnings date?

PAVmed Inc. is expected to report around November 12, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were PAVmed Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, PAVmed Inc. reported revenue of $33K and a net loss of $5.4M. The figures come from its filing with the SEC.

Is PAVmed Inc.'s revenue growing?

Revenue in Q2 FY2026 was $33K, up 450% from $6K in the same quarter a year earlier.

Get an email when PAVM reports

Follow PAVM and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when PAVM files with the SEC.

Source: quarterly figures PAVmed Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about PAVmed Inc.